Azenta Inc. (AZTA:NASD)の戦略的SWOTと財務分析

Report Overview

Report Summary

Azenta Inc. Strategic SWOT Analysis and Financial Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Azenta Inc.’s business operations. It provides a detailed analysis of the company’s financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.

The report begins with in-depth information about Azenta Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.

Next, the report assesses Azenta Inc.’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Azenta Inc.’s overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Azenta Inc.’s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Azenta Inc.’s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors’ operations.

Finally, the report includes recent news and deal activities undertaken by Azenta Inc. enhancing awareness of the company’s business trends, growth perspectives, and more.

Key Highlights

Azenta Inc., founded in 1978 and formerly known as Brooks Automation until its rebranding in December 2021, is a leading provider of innovative life sciences solutions. Headquartered at 200 Summit Drive in Burlington, Massachusetts, United States, the company drives advancements in sample management, automation, genomics, and cryogenic storage to accelerate scientific discoveries and therapies. Operating primarily in the healthcare sector specifically medical instruments and supplies Azenta delivers products and services across two key segments: Life Sciences Products and Life Sciences Services. These offerings support experimental design, gene sequencing, sample analysis, and consultation for biotech and pharmaceutical clients worldwide. Azenta maintains a robust global presence, with significant market share in North America, Europe (including the U.K. and Rest of Europe), Asia-Pacific, and China. Laboratories, biorepositories, and manufacturing facilities span these regions, enabling efficient service to international customers while employing around 3,300 professionals. This strategic footprint underscores Azenta’s commitment to fostering breakthroughs in life sciences on a global scale

Azenta Inc. in the News:-

2026-05-21 – Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
2026-05-05 – Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
2025-07-31 – Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology
2025-01-30 – Azenta Announces the Election of Dipal Doshi to its Board of Directors
2025-01-23 – UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence

Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Azenta Inc.’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Azenta Inc.’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company’s future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Azenta Inc.’s main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Azenta Inc.’s internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Azenta Inc.:

• Azenta Inc. PESTLE Analysis
• Azenta Inc. Value Chain Analysis
• Azenta Inc. Porter’s Five Forces Analysis
• Azenta Inc. VRIO Analysis
• Azenta Inc. BCG Analysis
• Azenta Inc. Segmentation, Targeting and Positioning (STP) Analysis
• Azenta Inc. Ansoff Matrix Analysis

Table of Contents

Table of Contents 2
Tables 5
Charts 6
Azenta Inc. – Key Company Facts 7
Azenta Inc. – Company Description 8
Azenta Inc. – Top Executives 9
Azenta Inc. – Head Office & Locations 10
Head Office – Country 10
Azenta Inc. – Products and Services 11
Products 11
Services 12
Azenta Inc. – Corporate Strategy 13
Azenta Inc. – Business Description 17
Sample Management Solutions 17
Multiomics 18
Azenta Inc. – ESG Spotlight 20
Environment 20
Social 21
Corporate Governance 22
Azenta Inc. – SWOT Analysis 24
Overview 24
Strengths 26
Weaknesses 29
Opportunities 31
Threats 32
Azenta Inc. – Financial Deep Dive 34
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 34
Profit and Loss Statement 36
Summary of Profit and Loss Statement 36
Balance Sheet 40
Summary of Balance Sheet 40
Cash Flow Statement 44
Summary of Cash Flow Statement 44
Key Financial Ratio Analysis 48
Azenta Inc. – Ratio Charts 50
Activity Ratio Charts 50
Growth Ratios Charts 51
Leverage Ratio Charts 55
Liquidity Ratio Charts 57
Profitability Ratio Charts 59
Competing Players 61
Snapshot of Competing Players 62
Eurofins Scientific SE 62
Key Company Facts 62
Company Description 62
Key Financials 63
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 63
Key Financial Ratio Analysis 68
Laboratory Corporation of America Holdings 70
Key Company Facts 70
Company Description 70
Key Financials 71
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 71
Key Financial Ratio Analysis 76
Thermo Fisher Scientific Inc 78
Key Company Facts 78
Company Description 78
Thermo Fisher Scientific Inc. – SWOT Spotlight 79
Thermo Fisher Scientific Inc. – PESTLE Spotlight 81
Key Financials 83
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 83
Key Financial Ratio Analysis 88
GenScript Biotech Corporation 90
Key Company Facts 90
Company Description 90
Key Financials 91
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 91
Key Financial Ratio Analysis 96
BGI Genomics Co Ltd 98
Key Company Facts 98
Company Description 98
Key Financials 99
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 99
Key Financial Ratio Analysis 104
Azenta Inc. – In the News 106
31-Jul-2025 – Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology 106
Azenta Inc. – Key Deals 108
04-Jun-2025 – Azenta Announces Collaboration with the Crohn’s & Colitis Foundation to Support its Crohn’s Disease and Ulcerative Colitis Clinical Research 108
13-May-2025 – Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development 109
Appendix 110
Definitions 110
SWOT Analysis 110
PESTLE Analysis 110
Value Chain Analysis 110
ESG Spotlight 110
Financial Deep Dive 110
Financial Ratios 111
Activity Ratios 111
Growth Ratios 113
Leverage Ratios 116
Liquidity Ratios 118
Market Ratios 120
Profitability Ratios 122
Research Methodology 124
Disclaimer 125
Contact Us 125

List of Tables

Table 1: Azenta Inc. – Company Facts 7
Table 2: Azenta Inc. – Digital Presence 7
Table 3: Azenta Inc. – Top Executives 9
Table 4: Azenta Inc. – Products 11
Table 5: Azenta Inc. – Services 12
Table 6: Azenta Inc. – Share Price Trend – Jun-2025 to Jun-2026 34
Table 7: Azenta Inc. – Profit and Loss Statement – 2022-2025 37
Table 8: Azenta Inc. – Balance Sheet – 2022-2025 41
Table 9: Azenta Inc. – Cash Flow Statement – 2022-2025 45
Table 10: Azenta Inc. – Ratio Analysis – 2022-2025 48
Table 11: Azenta Inc. – Competing Players 61
Table 12: Competing Players – Eurofins Scientific SE – Key Company Facts 62
Table 13: Eurofins Scientific SE – Share Price Trend – Jun-2025 to Jun-2026 63
Table 14: Competing Players – Eurofins Scientific SE – Profit and Loss Statement – 2022-2025 65
Table 15: Eurofins Scientific SE – Balance Sheet 2022-2025 66
Table 16: Eurofins Scientific SE – Cash Flow Statement 2022-2025 67
Table 17: Eurofins Scientific SE – Ratio Analysis – 2022-2025 68
Table 18: Competing Players – Laboratory Corporation of America Holdings – Key Company Facts 70
Table 19: Laboratory Corporation of America Holdings – Share Price Trend – Jun-2025 to Jun-2026 71
Table 20: Competing Players – Laboratory Corporation of America Holdings – Profit and Loss Statement – 2022-2025 73
Table 21: Laboratory Corporation of America Holdings – Balance Sheet 2022-2025 74
Table 22: Laboratory Corporation of America Holdings – Cash Flow Statement 2022-2025 75
Table 23: Laboratory Corporation of America Holdings – Ratio Analysis – 2022-2025 76
Table 24: Competing Players – Thermo Fisher Scientific Inc. – Key Company Facts 78
Table 25: Thermo Fisher Scientific Inc. – Share Price Trend – Jun-2025 to Jun-2026 83
Table 26: Competing Players – Thermo Fisher Scientific Inc. – Profit and Loss Statement – 2022-2025 85
Table 27: Thermo Fisher Scientific Inc. – Balance Sheet 2022-2025 86
Table 28: Thermo Fisher Scientific Inc. – Cash Flow Statement 2022-2025 87
Table 29: Thermo Fisher Scientific Inc. – Ratio Analysis – 2022-2025 88
Table 30: Competing Players – GenScript Biotech Corporation – Key Company Facts 90
Table 31: GenScript Biotech Corporation – Share Price Trend – Jun-2025 to Jun-2026 91
Table 32: Competing Players – GenScript Biotech Corporation – Profit and Loss Statement – 2022-2025 93
Table 33: GenScript Biotech Corporation – Balance Sheet 2022-2025 94
Table 34: GenScript Biotech Corporation – Cash Flow Statement 2022-2025 95
Table 35: GenScript Biotech Corporation – Ratio Analysis – 2022-2025 96
Table 36: Competing Players – BGI Genomics Co Ltd – Key Company Facts 98
Table 37: BGI Genomics Co Ltd – Share Price Trend – Jun-2025 to Jun-2026 99
Table 38: Competing Players – BGI Genomics Co Ltd – Profit and Loss Statement – 2022-2025 101
Table 39: BGI Genomics Co Ltd – Balance Sheet 2022-2025 102
Table 40: BGI Genomics Co Ltd – Cash Flow Statement 2022-2025 103
Table 41: BGI Genomics Co Ltd – Ratio Analysis – 2022-2025 104

List of Figures

Figure 1: Azenta Inc. – SWOT Analysis 25
Figure 2: Azenta Inc. – Average Share Price Trend – Jun-2025 to Jun-2026 35
Figure 3: Azenta Inc. – Profit and Loss Statement – 2022-2025 39
Figure 4: Azenta Inc. – Balance Sheet – 2022-2025 43
Figure 5: Azenta Inc. – Cash Flow Statement 2022-2025 47
Figure 6: Azenta Inc. – Activity Ratio Charts 50
Figure 7: Azenta Inc. – Growth Ratio Charts (Value %) 51
Figure 8: Azenta Inc. – Leverage Ratio Charts 55
Figure 9: Azenta Inc. – Liquidity Ratio Charts 57
Figure 10: Azenta Inc. – Profitability Ratio Charts (Value %) 59
Figure 11: Eurofins Scientific SE – Average Share Price Trend – Jun-2025 to Jun-2026 64
Figure 12: Eurofins Scientific SE – Profit and Loss Statement – 2022-2025 65
Figure 13: Eurofins Scientific SE – Balance Sheet – 2022-2025 66
Figure 14: Eurofins Scientific SE – Cash Flow Statement 2022-2025 67
Figure 15: Laboratory Corporation of America Holdings – Average Share Price Trend – Jun-2025 to Jun-2026 72
Figure 16: Laboratory Corporation of America Holdings – Profit and Loss Statement – 2022-2025 73
Figure 17: Laboratory Corporation of America Holdings – Balance Sheet – 2022-2025 74
Figure 18: Laboratory Corporation of America Holdings – Cash Flow Statement 2022-2025 75
Figure 19: Competing Players – Thermo Fisher Scientific Inc. – SWOT Spotlight 80
Figure 20: Competing Players – Thermo Fisher Scientific Inc. – PESTLE Spotlight 82
Figure 21: Thermo Fisher Scientific Inc. – Average Share Price Trend – Jun-2025 to Jun-2026 84
Figure 22: Thermo Fisher Scientific Inc. – Profit and Loss Statement – 2022-2025 85
Figure 23: Thermo Fisher Scientific Inc. – Balance Sheet – 2022-2025 86
Figure 24: Thermo Fisher Scientific Inc. – Cash Flow Statement 2022-2025 87
Figure 25: GenScript Biotech Corporation – Average Share Price Trend – Jun-2025 to Jun-2026 92
Figure 26: GenScript Biotech Corporation – Profit and Loss Statement – 2022-2025 93
Figure 27: GenScript Biotech Corporation – Balance Sheet – 2022-2025 94
Figure 28: GenScript Biotech Corporation – Cash Flow Statement 2022-2025 95
Figure 29: BGI Genomics Co Ltd – Average Share Price Trend – Jun-2025 to Jun-2026 100
Figure 30: BGI Genomics Co Ltd – Profit and Loss Statement – 2022-2025 101
Figure 31: BGI Genomics Co Ltd – Balance Sheet – 2022-2025 102
Figure 32: BGI Genomics Co Ltd – Cash Flow Statement 2022-2025 103

---

---